Abstract:<p>Triggering receptor expressed on myeloid cells-1 (TREM-1) was found to be induced in the context of subarachnoid hemorrhage (SAH) before. This study further investigates its role in the development of SAH-induced early brain injury (EBI). Firstly, rats were randomly divided into Sham and SAH groups for analysis of temporal patterns and cellular localization of TREM-1. Secondly, TREM-1 intervention was administrated to produce Sham, vehicle, antagonist and agonist groups, for analyzing TREM-1, Toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88) and NF-κB expressions at 24 h post-modeling, and EBI assessment at 24 h and 72 h. Thirdly, TLR4 inhibitor (TAK-242) was exploited to produce Sham, Sham+TAK-242, SAH, and SAH + TAK-242 groups to analyze the effects of TLR4 inhibition on TREM-1 induction and EBI evaluation at 72 h. Fourthly, the relationship of soluble TREM-1 (sTREM-1) levels in cerebrospinal fluid of SAH patients with Hunt-Hess grades were explored. The results showed that TREM-1 increased in the brain after experimental SAH (eSAH) early at 6 h and peaked at 48 h, which was found to be located in microglia and endothelial cells. TREM-1 inhibition attenuated EBI associated with TLR4/MyD88/NF-κB suppression, while enhancement had the opposite effects. Contrarily, TLR4 inhibition prevented TREM-1 induction and ameliorated EBI. In addition, sTREM-1 levels in SAH patients positively correlated with Hunt-Hess grades. Overall, the present study provides new evidence that TREM-1 increases dynamically in the brain after eSAH and it is located in microglia and endothelial cells, which may aggravate EBI by interacting with TLR4 pathway. And sTREM-1 in patients might act as a monitoring biomarker of EBI, providing new insights for future studies.</p>

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of TREM - 1 (Triggering Receptor Expressed on Myeloid Cells - 1) in the development of early brain injury (EBI) after subarachnoid hemorrhage (SAH). Specifically, the research aims to: 1. **Clarify the temporal change pattern and cellular localization of TREM - 1**: Researchers first analyzed the expression time pattern of TREM - 1 after experimental subarachnoid hemorrhage (eSAH) and its cellular localization in the brain. 2. **Evaluate the effect of TREM - 1 intervention on the TLR4/MyD88/NF - κB signaling pathway**: By using agonists and antagonists of TREM - 1, researchers evaluated the effect of TREM - 1 on the expressions of TLR4, MyD88 and NF - κB after eSAH, and how these changes affect the degree of early brain injury. 3. **Verify the effect of TLR4 inhibition on TREM - 1 expression and EBI**: Researchers further explored the effect of TLR4 inhibitor (TAK - 242) on TREM - 1 expression and evaluated its improvement effect on early brain injury. 4. **Explore the relationship between sTREM - 1 level and clinical grading of patients**: Researchers also analyzed the relationship between the level of soluble TREM - 1 (sTREM - 1) in the cerebrospinal fluid of patients with subarachnoid hemorrhage and their Hunt - Hess grading to determine whether sTREM - 1 can be used as a biomarker for monitoring early brain injury. ### Summary of main research contents - **Temporal change pattern of TREM - 1**: The study found that after experimental subarachnoid hemorrhage, TREM - 1 began to increase at 6 hours, peaked at 48 hours, and then gradually decreased. - **Cellular localization of TREM - 1**: TREM - 1 was mainly located in microglia and vascular endothelial cells, but not in oligodendrocytes. - **Effect of TREM - 1 intervention**: TREM - 1 enhancement (through agonists) aggravated early brain injury, while TREM - 1 inhibition (through antagonists) alleviated this injury. In addition, the activation of TREM - 1 significantly up - regulated the expressions of TLR4, MyD88 and NF - κB, while inhibition had the opposite effect. - **Effect of TLR4 inhibition**: The TLR4 inhibitor TAK - 242 not only inhibited the expression of TLR4, but also reduced the induction of TREM - 1, and significantly improved neurological deficits, brain edema and blood - brain barrier disruption. - **Relationship between sTREM - 1 and Hunt - Hess grading**: The level of sTREM - 1 in the cerebrospinal fluid of patients was positively correlated with Hunt - Hess grading, indicating that sTREM - 1 may be a potential biomarker for early brain injury. In conclusion, this study provides new evidence that TREM - 1 plays an important role in the development of early brain injury after subarachnoid hemorrhage, and may exacerbate the inflammatory response through interaction with the TLR4 signaling pathway. Meanwhile, the level of sTREM - 1 may become a useful indicator for monitoring early brain injury.

Role of TREM-1 in the development of early brain injury after subarachnoid hemorrhage

TREM1 Regulates Neuroinflammatory Injury by Modulate Proinflammatory Subtype Transition of Microglia and Formation of Neutrophil Extracellular Traps via Interaction With SYK in Experimental Subarachnoid Hemorrhage

TREM2 Activation Attenuates Neuroinflammation and Neuronal Apoptosis Via PI3K/Akt Pathway after Intracerebral Hemorrhage in Mice.

Identification and Validation of TREM2 in Intracranial Aneurysms

Role and mechanism of microglia in early brain injury after subarachnoid hemorrhage

TREM2 improves neurological dysfunction and attenuates neuroinflammation, TLR signaling and neuronal apoptosis in the acute phase of intracerebral hemorrhage

Endothelial TREM‐1 receptor regulates the blood–brain barrier integrity after intracerebral hemorrhage in mice via SYK/β‐catenin signaling

Advance of TREM-1 and Its Role in Sepsis

TREM2 Alleviates Subarachnoid Hemorrhage-Induced Brain Injury through Attenuating Neuroinflammation and Programmed Cell Death in Vivo and in Vitro

TREM2 alleviates long-term cognitive dysfunction after subarachnoid hemorrhage in mice by attenuating hippocampal neuroinflammation via PI3K/Akt signaling pathway

TREM (Triggering Receptor Expressed on Myeloid Cells)-1 Inhibition Attenuates Neuroinflammation via PKC (Protein Kinase C) δ/CARD9 (Caspase Recruitment Domain Family Member 9) Signaling Pathway After Intracerebral Hemorrhage in Mice.

Inhibition of TREM-1 alleviates neuroinflammation by modulating microglial polarization via SYK/p38MAPK signaling pathway after traumatic brain injury

TREM1 promotes neuroinflammation after traumatic brain injury in rats: Possible involvement of ERK/cPLA2 signalling pathway

sTREM-1 promotes the phagocytic function of microglia to induce hippocampus damage via the PI3K–AKT signaling pathway

TREM-1 inhibition or ondansetron administration ameliorates NLRP3 inflammasome and pyroptosis in traumatic brain injury-induced acute lung injury

Microglial TREM-1 Receptor Mediates Neuroinflammatory Injury Via Interaction with SYK in Experimental Ischemic Stroke.

Downregulation of TREM2/NF-кB signaling may damage the blood-brain barrier and aggravate neuronal apoptosis in experimental rats with surgically injured brain

Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity

Soluble Trem2 is a negative regulator of erythrophagocytosis after intracerebral hemorrhage in a CD36 receptor recycling manner.

Activation of triggering receptor expressed on myeloid cells-1 protects monocyte from apoptosis through regulation of myeloid cell leukemia-1.

Trem-1 As A Potential Therapeutic Target in Neonatal Sepsis